News - Appointments

Jean-Luc Vandebroek becomes CFO at Bone Therapeutics

Jean-Luc Vandebroek

Jean-Luc Vandebroek has joined Bone Therapeutics SA as chief financial officer to help develop a commercial strategy for the company’s clinical-stage portfolio of cell therapies for bone dise

Country: Belgium

Read more

Fredrik Järrsten appointed CFO at Karolinska Development

Fredrik Järrsten

Fredrik Järrsten has been appointed chief financial officer at Karolinska Development AB, the Stockholm-based investment group.

Country: Sweden

Read more

Novartis appoints Bertrand Bodson as chief digital officer

Bertrand Bodson

Bertrand Bodson, a former consultant and social networking entrepreneur, has been appointed to the new position of chief digital officer at Novartis to oversee the company’s application of da

Country: Switzerland

Read more

Thomas Eklund becomes chair of Pharmalink

Thomas Eklund

Thomas Eklund, an experienced financial executive, has been named chairman of the board of directors of Pharmalink AB, which has a late-stage clinical programme targeting IgA nephropathy.

Country: Sweden

Read more

Fredrik Johansson becomes CFO at Pharmalink

Fredrik Johansson

Sweden-based Pharmalink AB has appointed Fredrik Johansson to the position of chief financial officer, replacing Anders Hultman who has moved into the position of finance director.

Country: Sweden

Read more

Allan Reine becomes CFO at Pieris

Allan Reine

Allan Reine, an investment professional, has become chief financial officer at Pieris Pharmaceuticals Inc which is developing protein-based drugs to treat cancer and respiratory diseases.

Country: United States

Read more

David Lawrence is CFO at Valneva

David Lawrence

The France-based vaccine company Valneva SE has appointed David Lawrence, an experienced financial executive, as its chief financial officer.

Country: France

Read more

Reza Safaei heads medical affairs at Nordic Nanovector

Reza Safaei

Reza Safaei, an experienced biotech executive, has joined Nordic Nanovector ASA as head of medical affairs to help the Norwegian company complete development and commercialise its antibody radionuc

Country: Norway

Read more

Mike Owen becomes director at Glythera

Mike Owen

Mike Owen, a former executive at GlaxoSmithKline Plc, has become a non-executive director at Glythera Ltd, a UK company developing antibody drug conjugates.

Country: United Kingdom

Read more

Ernst-Ludwig Winnacker chairs Medigene scientific advisory board

Ernst-Ludwig Winnacker

Medigene AG has appointed eight experts to a new scientific advisory board that will guide management on its immuno-oncology strategy.

Country: Germany

Read more